| Not Yet Recruiting | A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of HIV/AIDS Complicated With Infectio NCT06280001 | Zhejiang University | — |
| Unknown | Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City NCT05685641 | National Institute of Respiratory Diseases, Mexico | N/A |
| Completed | Managing Hypertension Among People Living With HIV NCT05031819 | Dr. Dike Ojji | N/A |
| Not Yet Recruiting | Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxici NCT05493969 | Shanghai Public Health Clinical Center | Phase 4 |
| Active Not Recruiting | Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-I NCT04983030 | Boris Juelg, MD PhD | Phase 1 / Phase 2 |
| Completed | Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men NCT04772469 | University of California, San Francisco | N/A |
| Completed | Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS NCT03746600 | Carolyn Lauckner | N/A |
| Unknown | HIV Indicator Diseases in Hospital and Primary Care NCT05225493 | Erasmus Medical Center | — |
| Completed | Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Dia NCT04192487 | Napo Pharmaceuticals, Inc. | Phase 4 |
| Completed | POC Strategies to Improve TB Care in Advanced HIV Disease NCT04122404 | University of Southern Denmark | N/A |
| Completed | A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk NCT02929069 | Yale University | N/A |
| Unknown | Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine NCT02762045 | Centers for Disease Control and Prevention, China | Phase 1 |
| Completed | Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria NCT02639754 | Medical College of Wisconsin | N/A |
| Recruiting | Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus NCT02479698 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Accuracy Evaluation of the BD FACS Presto System NCT02396355 | Becton, Dickinson and Company | — |
| Completed | Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART NCT02322827 | Olayemi Osiyemi MD | — |
| Unknown | HIV Medication Adherence in Underserved Populations NCT02392884 | Cedars-Sinai Medical Center | N/A |
| Completed | Peripheral Arterial Insufficiency Associated With HIV/AIDS NCT02264509 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | — |
| Completed | Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg. NCT02583464 | Laboratorio Elea Phoenix S.A. | Phase 1 |
| Completed | DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients NCT02116179 | University of Delaware | N/A |
| Completed | HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) NCT03583138 | Yale University | — |
| Completed | Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer NCT01590017 | AIDS Malignancy Consortium | Phase 2 |
| Completed | Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation NCT03777371 | Kanuni Sultan Suleyman Training and Research Hospital | — |
| Completed | Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elviteg NCT01967940 | Gilead Sciences | Phase 3 |
| Completed | Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Daruna NCT01968551 | Gilead Sciences | Phase 3 |
| Unknown | Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS NCT01881581 | Centers for Disease Control and Prevention, China | Phase 1 |
| Completed | Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda NCT01916759 | Emory University | N/A |
| Completed | Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients NCT01671501 | University of California, San Francisco | N/A |
| Completed | Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and T NCT02348177 | Drugs for Neglected Diseases | Phase 4 |
| Completed | Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate NCT01721109 | Gilead Sciences | Phase 2 / Phase 3 |
| Completed | Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatme NCT01705574 | Gilead Sciences | Phase 3 |
| Unknown | Pilot Study of Immediate HIV Treatment in Guangxi, China NCT01892228 | National Center for AIDS/STD Control and Prevention, China CDC | N/A |
| Completed | D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults NCT01565850 | Gilead Sciences | Phase 2 |
| Completed | Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV NCT01433185 | University of Washington | N/A |
| Completed | HIV, Buprenorphine, and the Criminal Justice System NCT01550341 | Yale University | N/A |
| Completed | Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya NCT01425073 | University of Washington | N/A |
| Completed | Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenof NCT01533259 | Gilead Sciences | Phase 3 |
| Unknown | Dimiracetam in Painful Neuropathies Affecting AIDS Patients NCT01444690 | Neurotune AG | Phase 2 |
| Completed | Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Tre NCT01497899 | Gilead Sciences | Phase 2 |
| Completed | Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus E NCT01495702 | Gilead Sciences | Phase 3 |
| Completed | Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitab NCT01475838 | Gilead Sciences | Phase 3 |
| Completed | A Commitment Device for Medication Adherence Among HIV Patients NCT01455740 | National Bureau of Economic Research, Inc. | N/A |
| Completed | Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults NCT01440569 | Gilead Sciences | Phase 3 |
| Completed | Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate R NCT01363011 | Gilead Sciences | Phase 3 |
| Completed | Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, NCT02630082 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | Managerial Database II NCT01322217 | University of North Carolina, Chapel Hill | — |
| Completed | Stanford Universities: The Stanford HIV Aging Cohort NCT01401348 | Stanford University | — |
| Completed | Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM) NCT01502618 | University of North Carolina, Chapel Hill | N/A |
| Completed | Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After M NCT01186575 | University of Washington | N/A |
| Completed | HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence NCT01369056 | University of Tartu | N/A |
| Completed | Mesalamine to Reduce T Cell Activation in HIV Infection NCT01090102 | University of California, San Francisco | Phase 4 |
| Completed | Chinese Network of Pediatric Antiretroviral Therapy NCT01210924 | National Center for AIDS/STD Control and Prevention, China CDC | — |
| Completed | Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program NCT00947947 | University of North Carolina, Chapel Hill | Phase 2 |
| Completed | Clinic-based ART Diagnostic Evaluation NCT01791556 | Walter Reed Army Institute of Research (WRAIR) | N/A |
| Completed | Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia NCT02396979 | Yale University | Phase 4 |
| Completed | Medications for Chronic HIV: Education and Collaboration NCT01038076 | Boston University | N/A |
| Terminated | Pilot Assessment of Lopinavir/Ritonavir and Maraviroc NCT00981318 | Rodwick, Barry M., M.D. | Phase 4 |
| Completed | An Expanded Safety Study of Dapivirine Gel 4759 in Africa NCT00917891 | International Partnership for Microbicides, Inc. | Phase 1 / Phase 2 |
| Completed | HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth NCT01401335 | Stanford University | N/A |
| Completed | Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. NCT00985543 | Kirby Institute | Phase 1 |
| Completed | TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) Whe NCT00896051 | Janssen R&D Ireland | Phase 2 |
| Completed | An Expanded Safety Study of Dapivirine Gel 4789 in Africa NCT00917904 | International Partnership for Microbicides, Inc. | Phase 1 / Phase 2 |
| Completed | A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleo NCT00903682 | Janssen-Cilag International NV | Phase 2 |
| Completed | Safety of Cotrimoxazole in HIV- and HAART-exposed Infants NCT01086878 | Harvard School of Public Health (HSPH) | Phase 4 |
| Completed | Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV NCT00908284 | University of Miami | N/A |
| Unknown | Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIV NCT01230580 | Medical Research Council | Phase 4 |
| Completed | Spatial Epidemiology of HIV Infection NCT01377272 | National Taiwan University Hospital | — |
| Unknown | Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis NCT01315301 | Karolinska Institutet | N/A |
| Completed | Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients NCT00871078 | Federal University of São Paulo | — |
| Completed | Efficacy of HIV Post-Test Support for ANC in South Africa NCT01683461 | University of North Carolina, Chapel Hill | N/A |
| Completed | Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED) NCT00551330 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5) NCT00523211 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Multicenter, Safety Study Of Maraviroc NCT00478231 | ViiV Healthcare | Phase 3 |
| Completed | Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) NCT00474370 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring NCT00434070 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials NCT00394004 | National Institutes of Health Clinical Center (CC) | — |
| Completed | Examining the Link Between Heart Disease and HIV Infection in Women NCT00312468 | Albert Einstein College of Medicine | — |
| Completed | A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic A NCT00381212 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 1 / Phase 2 |
| Completed | Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis NCT00698334 | All India Institute of Medical Sciences | Phase 3 |
| Completed | Computer Assisted Rx Education for HIV-Positives: CARE+ NCT00443378 | University of Washington | N/A |
| Completed | The Efficacy of the HIV/AIDS Symptom Management Manual NCT00241202 | University of California, San Francisco | N/A |
| Withdrawn | Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR- NCT00243568 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | HIV Prevention Intervention for Couples NCT00325585 | National Development and Research Institutes, Inc. | Phase 2 |
| Completed | Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing NCT00105157 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adheren NCT00344591 | University of California, San Francisco | Phase 2 |
| Completed | A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COM NCT00100048 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV NCT00602758 | University of Missouri, Kansas City | N/A |
| Unknown | PI Vs. NNRTI Based Therapy for HIV Advanced Disease NCT00162643 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 4 |
| Completed | Longitudinal Study of HAART, Social Networks, & Adherence NCT00272220 | University of Washington | N/A |
| Completed | Retrovirus Epidemiology Donor Study-II (REDS-II) NCT00097006 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Efficacy of Elevated CD4 Counts on CMV Retinitis NCT00091884 | National Eye Institute (NEI) | — |
| Unknown | Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on No NCT00172315 | National Taiwan University Hospital | — |
| Completed | Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS NCT02191215 | Boehringer Ingelheim | — |
| Completed | Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV NCT00144157 | Boehringer Ingelheim | Phase 4 |
| Completed | Analysis of Immune Responses to HIV Vaccines NCT00068978 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmis NCT00144183 | Boehringer Ingelheim | Phase 3 |
| Completed | Multidisciplinary Inpatient Palliative Care Intervention NCT00325611 | Kaiser Permanente | N/A |
| Completed | Treatment of Depression With Massage in HIV NCT00033852 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adul NCT00273988 | Boehringer Ingelheim | Phase 4 |
| Completed | The Use of Reiki for Patients With Advanced AIDS NCT00032721 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Immune Restoration by Lipoic Acid in AIDS NCT00033176 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Once-Daily Drug Regimen for HIV-Infected Patients NCT00001968 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | KSHV Infection in Blood Donors From Texas NCT00006310 | The University of Texas Health Science Center at San Antonio | — |
| Completed | CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes NCT00966160 | University of Cologne | Phase 3 |
| Completed | Longitudinal Study of Ocular Complications of AIDS (LSOCA) NCT00000168 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers NCT00001699 | National Cancer Institute (NCI) | — |
| Completed | Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Av NCT00001763 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients NCT00001650 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | White Blood Cell Infusions to Treat HIV Infection NCT00001647 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis NCT00001646 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | Immune Activity Against CVM Retinitis NCT00001611 | National Eye Institute (NEI) | — |
| Completed | Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers NCT00001560 | National Cancer Institute (NCI) | — |
| Completed | Fluconazole Prophylaxis of Thrush in AIDS NCT00001542 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Completed | Thalidomide to Treat Oral Lesions in HIV-Infected Patients NCT00001524 | National Institute of Dental and Craniofacial Research (NIDCR) | Phase 2 |
| Completed | Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits NCT00001500 | National Cancer Institute (NCI) | — |
| Completed | Twins Study of Gene Therapy for HIV Infection NCT00001535 | National Human Genome Research Institute (NHGRI) | Phase 1 |
| Completed | Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers NCT00001538 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection NCT00001443 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist NCT00001475 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV NCT00004664 | National Center for Research Resources (NCRR) | N/A |
| Completed | Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children NCT00001435 | National Cancer Institute (NCI) | — |
| Completed | Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis NCT00004794 | National Center for Research Resources (NCRR) | Phase 2 |
| Completed | Evaluation and Natural History of Children With Cancer and AIDS NCT00001424 | National Cancer Institute (NCI) | — |
| Completed | Viral Activation Transfusion Study (VATS) NCT00000593 | National Heart, Lung, and Blood Institute (NHLBI) | N/A |
| Completed | Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications NCT00001409 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Tuberculosis in a Multiethnic Inner City Population NCT00005379 | NYU Langone Health | — |
| Completed | Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelop NCT00001386 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical T NCT00001353 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Interleukin-2 Therapy for HIV Infection - Supplemental Procedures NCT00001354 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) NCT00000134 | Johns Hopkins Bloomberg School of Public Health | Phase 3 |
| Completed | Ganciclovir Implant Study for Cytomegalovirus Retinitis NCT00000118 | National Eye Institute (NEI) | Phase 3 |
| Completed | HIV Diversity and Pathogenesis in Donor-Recipient Clusters NCT00005360 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Cardiac Autonomic Control in Children of HIV Positive Mothers NCT00005353 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185) NCT00000590 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous NCT00001267 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Prospective Study of HIV Infection in Hemophiliacs NCT00005309 | Bloodworks | — |
| Completed | Retrovirus Epidemiology Donor Study I (REDS I) NCT00005278 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) NCT00005274 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection NCT00000587 | Thomas Jefferson University | Phase 2 |
| Completed | AIDS-Associated Heart Disease -- Incidence and Etiology NCT00005228 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | HIV-Associated Heart Disease NCT00005229 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | AIDS-Associated Cardiomyopathy NCT00005227 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Pati NCT00270283 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | Pulmonary Complications of HIV Infection Study (PACS) NCT00005273 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Effectiveness of AIDS Antibody Screening NCT00005303 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Transfusion Safety Study (TSS) NCT00005301 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS NCT00270270 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by T NCT00269945 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) NCT00270010 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Terminated | Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs NCT00051766 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |